Francisco Adrián
- Molecular Biology top 10%
- Hematology top 2%
- Oncology top 10%
- Public Health, Environmental and Occupational Health top 5%
- Genetics top 5%
- Topics
- Chronic Myeloid Leukemia Treatments (9 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)Chronic Lymphocytic Leukemia Research (6 papers)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Francisco Adrián
30 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 714
- Hematology 413
- Oncology 386
- Public Health, Environmental and Occupational Health 339
- Genetics 275
Countries citing papers authored by Francisco Adrián
This map shows the geographic impact of Francisco Adrián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Adrián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Adrián more than expected).
Fields of papers citing papers by Francisco Adrián
This network shows the impact of papers produced by Francisco Adrián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Adrián. The network helps show where Francisco Adrián may publish in the future.
Co-authorship network of co-authors of Francisco Adrián
This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Adrián. A scholar is included among the top collaborators of Francisco Adrián based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Adrián. Francisco Adrián is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 10 | |
| 3 | 11 | |
| 4 | 1 | |
| 5 | 85 | |
| 6 | 1 | |
| 7 | 119 | |
| 8 | 24 | |
| 9 | 2 | |
| 10 | 51 | |
| 11 | 18 | |
| 12 | 47 | |
| 13 | 58 | |
| 14 | 11 | |
| 15 | 325 | |
| 16 | 153 | |
| 17 | 124 | |
| 18 | 290 | |
| 19 | 99 | |
| 20 | 64 |
About Francisco Adrián
Francisco Adrián is a scholar working on Hematology, Physiology and Genetics, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Hematology (413 citations), Genetics (275 citations) and Computational Theory and Mathematics (230 citations). Francisco Adrián has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Nathanael S. Gray, Markus Warmuth, Gang Xia, Taebo Sim, Yi Liu, Xiang-ju Gu, Sung Joon Kim, Qiang Ding, Guobao Zhang and Jürgen Mestan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.